Page 1,214«..1020..1,2131,2141,2151,216..1,2201,230..»

Duke Researchers Garner Over $6 Million in NIH Funding to Fight Genetic Diseases – Duke Today

Posted: January 5, 2020 at 4:10 am

Hemophilia. Cystic fibrosis. Duchenne muscular dystrophy. Huntingtons disease. These are just a few of the thousands of disorders caused by mutations in the bodys DNA. Treating the root causes of these debilitating diseases has become possible only recently, thanks to the development of genome editing tools such as CRISPR, which can change DNA sequences in cells and tissues to correct fundamental errors at the sourcebut significant hurdles must be overcome before genome-editing treatments are ready for use in humans.

Enter the National Institutes of Health Common Funds Somatic Cell Genome Editing (SCGE) program, established in 2018 to help researchers develop and assess accurate, safe and effective genome editing therapies for use in the cells and tissues of the body (aka somatic cells) that are affected by each of these diseases.

Todaywith three ongoing grants totaling more than $6 million in research fundingDuke University is tied with Yale University, UC Berkeley and UC Davis for the most projects supported by the NIH SCGE Program.

In the 2019 SCGE awards cycle, Charles Gersbach, the Rooney Family Associate Professor of Biomedical Engineering, and collaborators across Duke and North Carolina State University received two grants: the first will allow them to study how CRISPR genome editing affects engineered human muscle tissues, while the second project will develop new CRISPR tools to turn genes on and off rather than permanently alter the targeted DNA sequence. This work builds on a 2018 SCGE grant, led by Aravind Asokan, professor and director of gene therapy in the Department of Surgery, which focuses on using adeno-associated viruses to deliver gene editing tools to neuromuscular tissue.

There is an amazing team of engineers, scientists and clinicians at Duke and the broader Research Triangle coalescing around the challenges of studying and manipulating the human genome to treat diseasefrom delivery to modeling to building new tools, said Gersbach, who with his colleagues recently launched the Duke Center for Advanced Genomic Technologies (CAGT), a collaboration of the Pratt School of Engineering, Trinity College of Arts and Sciences, and School of Medicine. Were very excited to be at the center of those efforts and greatly appreciate the support of the NIH SCGE Program to realize this vision.

For their first grant, Gersbach will collaborate with fellow Duke biomedical engineering faculty Nenad Bursac and George Truskey to monitor how genome editing affects engineered human muscle tissue. Through their new project, the team will use human pluripotent stem cells to make human muscle tissues in the lab, specifically skeletal and cardiac muscle, which are often affected by genetic diseases. These systems will then serve as a more accurate model for monitoring the health of human tissues, on-target and off-target genome modifications, tissue regeneration, and possible immune responses during CRISPR-mediated genome editing.

Currently, most genetic testing occurs using animal models, but those dont always accurately replicate the human response to therapy, says Truskey, the Goodson Professor of Biomedical Engineering.

Bursac adds, We have a long history of engineering human cardiac and skeletal muscle tissues with the right cell types and physiology to model the response to gene editing systems like CRISPR. With these platforms, we hope to help predict how muscle will respond in a human trial.

Gersbach will work with Tim Reddy, a Duke associate professor of biostatistics and bioinformatics, and Rodolphe Barrangou, the Todd R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University, on the second grant. According to Gersbach, this has the potential to extend the impact of genome editing technologies to a greater diversity of diseases, as many common diseases, such as neurodegenerative and autoimmune conditions, result from too much or too little of certain genes rather than a single genetic mutation. This work builds on previous collaborations between Gersbach, Barrangou and Reddy developing both new CRISPR systems for gene regulation and to regulate the epigenome rather than permanently delete DNA sequences.

Aravind Asokan leads Dukes initial SCGE grant, which explores the the evolution of next generation of adeno-associated viruses (AAVs), which have emerged as a safe and effective system to deliver gene therapies to targeted cells, especially those involved in neuromuscular diseases like spinal muscular atrophy, Duchenne muscular dystrophy and other myopathies. However, delivery of genome editing tools to the stem cells of neuromuscular tissue is particularly challenging. This collaboration between Asokan and Gersbach builds on their previous work in using AAV and CRISPR to treat animal models of DMD.

We aim to correct mutations not just in the mature muscle cells, but also in the muscle stem cells that regenerate skeletal muscle tissue, explainsAsokan. This approach is critical to ensuring long-term stability of genome editing in muscle and ultimately we hope to establish a paradigm where our cross-cutting viral evolution approach can enable efficient editing in multiple organ systems.

Click through to learn more about the Duke Center for Advanced Genomic Technologies.

Excerpt from:
Duke Researchers Garner Over $6 Million in NIH Funding to Fight Genetic Diseases - Duke Today

Posted in Genetic Engineering | Comments Off on Duke Researchers Garner Over $6 Million in NIH Funding to Fight Genetic Diseases – Duke Today

Society can be controlled through its means of communication – The Conversation CA

Posted: January 5, 2020 at 4:10 am

Venezuelan philosopher, Antonio Pasquali, who wrote extensively about how media and society affected each other, passed away on Oct. 5, 2019, in Spain.

In 1984, Pasquali was appointed Deputy Director General of the Communications Sector of UNESCO and Regional Coordinator for Latin America and the Caribbean of UNESCO from 1986-1989. He played an important role in UNESCOs New World Information and Communication discussions.

Pasqualis contributions to media studies are well-known in Latin America, but his research is less known in the English-speaking world. His research on media and communication inspired many Latin American scholars and media practitioners including myself who place ethics at the centre of the discussion.

Pasquali was a fierce critic of Canadian media theorist Marshall McLuhans view that the medium is the message that the medium in which things are disseminated determines their meaning. Always returning to human communication as the basis of relationships betwwen people, Pasquali warned us about the necessary conceptual and practical difference between communication and media.

For Pasquali, the ability to communicate is inherent to the formation of society. And so, any modification or control of communications becomes to a modification or control of society itself. He argued that technological changes, with their benefits and disruptions, have yet to transform the essence of human communication.

Pasqualis work is important to consider because he warned us about some troubling challenges that we can see around us.

Pasquali wrote about the ethics of communication, or what he called the moral dimension of communication. In his book 18 essays about communications, he identified six hard trends that would mark humanitys future:

1) A process of human-made environmental degradation that approaches the point of no return, as in the impending ecological crisis brought about by climate change and its consequences;

Read more: Dealing with the absurdity of human existence in the face of converging catastrophes

2) Human interference in natural evolutionary processes. He warned that advances in genetic engineering that bring hope for the treatment of diseases and also open the door to sophisticated mechanisms of social engineering and control;

3) Challenging the very idea of what being human is by: a) machines combined with living beings (cyborgs), and b) by the shift of human decision-making to artificial intelligence that could make humans irrelevant and even disposable. This will require new ways of understanding the relations between digital machines and human;

4) The persistence of nuclear, bacteriological, chemical and terrorist dangers, in a context of political polarization coupled with the emergence of extremist ideologies that could lead to internal and external violent confrontations;

5) The consolidation of the disparity between rich and poor that is already generating social unrest in different regions, as we have seen recently in Latin America and the Middle East;

6) The transformation of democracy into a plutocratic dictatorship (the government by the wealthy) based on the technological manipulation of social consensus, as illustrated in the Cambridge Analytica/Facebook scandal.

Pasquali was persistent in his struggle to establish a public broadcasting service in Latin American countries. His passion in defence of the need for a public media service never declined, and seems to be more relevant than ever in the midst of the Internet explosion.

Pasquali observed that the internet is now largely controlled by monopolies such as Facebook, Google, Amazon and Apple, and manipulated by big emerging powers like China. He vehemently denounced the communication hegemony of the authoritarian government of Hugo Chvez and his successor Nicols Maduro. Pasquali documented the setbacks that the regime has inflicted on Venezuelan society from the point of view of telecommunications, the media and transportation infrastructure.

At the end of his essay Will we communicate or inform ourselves?, Pasquali wondered if we are ready to give up a fundamental condition for our existence the ability and experience of communication. For him, communication was a mixture of intellect, passions and will that was intrinsic to how people and made meaning, personally and socially. He asked: Are we going to give up without a fight the possibility of communicating to another human being that we love him/her?

The great body of work that Pasquali produced will help us to answer these fundamental questions about the future of communication. Pasqualis intellectual legacy will live on through his writings and teachings.

[ Expertise in your inbox. Sign up for The Conversations newsletter and get a digest of academic takes on todays news, every day. ]

Read this article:
Society can be controlled through its means of communication - The Conversation CA

Posted in Genetic Engineering | Comments Off on Society can be controlled through its means of communication – The Conversation CA

Getting the Most from Biotech: Precision Engineering and Partnership – BioSpace

Posted: January 5, 2020 at 4:10 am

We are Earths Tech Support, declared Randall Kirk, Executive Chairman of the Board of Directorsand former CEO ofIntrexon. Intrexonis one of the biggest developers of synthetic biology (or engineering biology) applications in therapeutics, agriculture and chemicals. Kirk gave a keynote speech atSynbio Marketson synthetic biologys struggle to break into mainstream markets and its revolutionary new approach for industrial biotech in the food, pharmaceuticals, chemicals and materials sectors.

Before these new technologies can save the world, they need to be accepted and get to market. Companies must overcome the usual hurdles in finding investment and meeting regulatory requirements. They must find compatible scale-up partners and face new challenges in communicating the benefits and safety of their novel technology to society.

Partnerships for Success

Collaborations are beginning to blossom in synthetic biology. The field is often likened to the silicon chip industry. In its infancy, a single company would design, build and use their own chips. Now, companies outsource the design, building, testing and manufacture of chips along a structured value chain thanks to standardization of parts and uniformity in the field. This took years to achieve. Synthetic biology companies are currently developing their own unique tools to perform new feats in engineering biotechnology. Standardization is the dream and, to achieve this, companies must work together to break into the market.

A striking partnership at the conference was that ofAMSilkandAirbus. The airline industry has a problem: they must increase fuel efficiency by reducing weight of their aircraft without compromising on safety. Composite materials are an alternative to hefty sheet metals and AMSilk produces a durable but lightweight material: synthetic spider silk. AMSilk is interesting for its energy absorption, which is important for safety of the aircraft, Detlev Konigorski of Airbus explains. This partnership could help Airbus develop safe new materials while helping the carbon footprint of the airline industry.

One of the kings of collaboration isGinkgo Bioworks. Ginkgo uses several automated platforms to speed up and precisely carry out genetic manipulation, growth and testing of cells. To build their analytical power, they collaborated withBerkeley Lights, whose technology allows functional screening of thousands of cells simultaneously, increasing throughput.

Ginkgo has used this actively in their healthcare collaborations, such as a recent team-up withSynlogic, a microbiome therapeutics company developing living medicines. Ginkgo used its platform to increase the potency of SynlogicsE. coli-based drug in non-human primates in less than a year. Ginkgo CCO Matt McKnight wants to build on these partnerships by partnering with early-stage companies. Theyrecently announced a $350 m platformto build companies using Ginkgos foundries. He foresees more partnerships in the synthetic biology space in future, I think we shouldnt have full stack engineering biology companies. In any discipline, we dont see this. People work together.

Chemicals giantBASFis also interested in partnering with synthetic biology companies. Markus Pompejus, Vice President for Innovation and Scouting addressed the conference in Berlin citing the companys wide range of products. In principal, many products could be produced with biotech methods. Synbio is a research topic, but biotech is the application, Pompejus says.

Partnering may be off-putting for early-stage companies who want to maximize ownership of their company and the topic came up repeatedly at Synbio Markets. Where do you draw the line? Where do you co-develop with customers or should you do it more yourself? asks session chair James Hallinan ofCambridge Consultants, an expert engineering firm.

Depends where you are, says Alexandre Zanghellini of protein design companyArzeda, The later you partner, the more value you capture. You certainly want to keep the process propriety until the point where it can be scaled, then partner with marketing, scale up and development partners.

Talking Tech and Selling Solutions

Synthetic biology exists at the nexus of biology and nearly every other field. Its less a field of study and more of a precision engineering approach to traditional biotechnology using standardized tools and platforms. Kirk argued in his speech humanity has been using synthetic biology for thousands of years, using crop breeding as an example of humans precisely selecting and breeding desirable traits to engineer better strains of corn, for example. Now our role in the world has changed.

Weve been doing it for 12,000 years and weve been doing it without thinking of the consequences. Synthetic biology allows us tremendous specificity and potential to solve world problems by targeting individual species, he said.

How does this help us synthetic biology products access new and existing markets? Every process has biology in it, McKnight says.InscriptasCCO Jason Gammack thinks the solution lies in getting a few tangible products to lead the way. We need to make the products tangible. In the US were in hyperdrive mode. Two years ago, there was very little. Now,Impossible Foodsis in Burger King, says Gammack. Gary Lin ofPurple Orange Venturesthinks we need to raise the profile of synthetic biology among the public, adding One of the hard challenges, we need policymakers and government funding to support this. The amount of capital gone into this space is a drop in the ocean.

The issue spills over into the regulation of gene-edited technologies, especially in Europe. We recently had a debate on CRISPR plants, says Nadine Bongaerts-Duportet ofScience MattersandHello Tomorrow. The European Union regulations says CRISPR-edited crops are defined as genetically modified (GM), while those edited by radiation exposure are not. Bongaerts adds, The difference between UV exposure and CRISPR [as gene-editing methods], everybody understands the regulations dont make sense. How do you, with a positive message, make sure everyone gets it? All the panelists agree that building trust is key.

The trust us, were scientists approach doesnt work because people dont understand the technology, according to Gammack. I would fault all the synbio community, says Kirk. We look at polling data on GMO attitudes, I thought healthcare would be the first area [accepted]. In terms of polling, people have the greatest acceptance to insect disease vectors, he says, citing IntrexonsOxitecand theirGM mosquitoas an example.

The messaging, particularly around GM and especially here in Europe, is a minefield. From our perspective, we need to be mindful of potential roadblocks, says Lin, GM in food is the most difficult to grapple with. Part of the process is creating awareness of what the food process looks like. Transparency and openness about the technology is a major factor in getting this technology to market.MonsantosFlavr Savr tomatodisaster is still fresh in peoples minds. Public acceptance to this technology is a must before the market can be broken into reliably.

We need to understand emotions and backgrounds of people we talk to, to link our advancements to the incentives they care about. We should not over-hype, because if you can be critical and open about it, people will trust you, says Bongaerts.

Originally posted here:
Getting the Most from Biotech: Precision Engineering and Partnership - BioSpace

Posted in Genetic Engineering | Comments Off on Getting the Most from Biotech: Precision Engineering and Partnership – BioSpace

How we’ll eat in the decade ahead – The Globe and Mail

Posted: January 5, 2020 at 4:10 am

My hope is that we pay more attention to the way we talk about food; dietary regimes have become a means of self-definition a set of rules to follow, a clan to be a part of, which creates the potential to become divisive.

iStockPhoto / Getty Images

In this part of the world, it will be increasingly difficult for small agricultural operators to survive, let alone compete in the years to come, says Tony Marshall, who with his wife, Penny, runs a small-scale organic farm in High River, Alta., that has been in the family since 1899. He predicts that the increasing cost of land, equipment and labour could limit growth of small family farms, which are also increasingly impacted by fluctuating weather patterns. In addition, he foresees the cost and sophistication of regulatory compliance, food safety, organic certification, etc., will increase to the point of being prohibitive for smaller producers and processors, leaving only large enterprises able to afford the implementation and ongoing maintenance of complex programs such as the Safe Food for Canadians Act, which became law in January, 2019.

Certain segments of the public will continue to pursue connections with the people growing and making their food, but overall the marketplace will gradually slip away from any direct association to the land and their food sources, Marshall says. Highly processed foods like Beyond Meat and other lab-based alternatives will exacerbate this disconnect. Increasing food security demands from a growing global population will put even more pressure on agricultural producers to embrace technologies such as genetic engineering, farmed fish and factory-grown designer meat.

Feeding a hungry world is as dependent on government policies, distribution and food waste as it is upon increasing production outputs, Marshall says. Addressing the problem of food waste, on the farm and during transport, storage, processing, distribution, in retail and by end-users, will be essential to resolving food security issues.

Story continues below advertisement

Im hoping restaurants will survive, restaurateur Tannis Ling says of the popular Bao Bei and Kissa Tanto in Vancouvers Chinatown, eateries that cultivate unique dining experiences with attention to decor, music, service and other details that are lost when food is ordered via delivery options, such as Uber Eats and DoorDash. Ling sees an increasing desire for fast casual, takeout and non-committal eateries that focus on just a few items, such as Juke Fried Chicken across the street from Bao Bei. Those who are doing it well are killing it, she says.

Though she has witnessed a dramatic shift in restaurant culture over the decades cooks, kitchen and front of house staff are paying more attention to their physical and mental health, and prioritizing a more manageable work-life balance Ling worries, as does the back of house operations manager Alain Chow, about staffing becoming even more challenging in the coming years. In a gig economy, many young people who have traditionally sought jobs in the food industry are opting to make money doing multiple smaller tasks, many of them virtual or digital. Were still finding passionate young cooks, Chow says, but retaining them is the hard part.

They both expect technology to have an ever-increasing presence in the coming decade, citing a local hot pot restaurant at which diners order from their tables on iPads, but believe that social media has hit a plateau in terms of its influence on the dining experience. With such a constant barrage of imagery and information, Ling says, it no longer has the same impact.

Big changes are gradual, almost imperceptible, but were in the midst of one, says educator, activist and historian Anita Stewart, who has been writing about food in Canada for almost 40 years, and this year will see the creation of her namesake Alumni Food Laboratory at the University of Guelph, a multifunctional lab and teaching studio that will enable hospitality and nutrition students to learn innovative practices in food preparation, production and food science.

Our food supply is among the best in the world and Canadian chefs, restaurateurs and even grocery chains with branding programs have adopted local/regional foods as a point of differentiation, she says. Even a generation ago, locally grown food was not commonplace on restaurant menus; today its almost a given that restaurants will support local farms and producers. Stewart sees that trend continuing, propelled by a rise in concern over the impact our food choices have on the environment. Reducing the miles our ingredients travel has to be a factor, she says.

My hope for the coming decade is that the industry be more collaborative, Stewart says. Look down, on whose shoulders are we standing? Look beside, whos travelling on a similar pathway? Look ahead, there are way too many silos and we need to build some bridges. We all, as consumers, need to be more grateful, introspective and well-informed advocates for Canadian agricultural and processing communities who are competing not only with the world, but increasingly devastating weather.

I probably check the weather three times a day, says Ann Sperling, winemaker and director at Canadas first biodynamic vineyard and winery, Southbrook Vineyards, in Ontarios Niagara on the Lake, and owner and winemaker at Sperling Vineyards in Kelowna, B.C.

Story continues below advertisement

Covering two growing regions in Canada, she says our wine industry is flourishing, and yet all regions Nova Scotia, Quebec, Ontario and British Columbia have had challenges in recent years, much related to erratic weather. More investments are being made to develop technology to mitigate environmental instability issues; textiles to cover vines in colder regions, wind machines to minimize frost risk and irrigation for periods of drought are just some of those innovations. But there are still no systems in place to deal with crop failures, and government has been reducing its support for the industry, and agriculture in general. Theres no bigger picture safeguard, she says. Were more on our own.

The more people realize there is an impact on climate, that C02 levels are rising, the more people will start to make their buying decisions based on environmental impact, Sperling says. The good news: By next year, B.C. will have one of the highest percentages of organic vine production in the world, at around 12 to 15 per cent.

Because, generally, we do not find wine as intimidating as it used to be, Sperling doesnt see new cannabis legislation affecting the industry; the two fit a different niche in peoples lives. And much of the industrys marketing is geared toward younger consumers, who have increasing buying power without the same biases of generations past. Theyre more inclined to try new things, Sperling says, and they think more globally in terms of how they spend their money.

A shift in attitude toward food excites me. At home, people are paying attention to food waste and learning to cook more intuitively, approaching mealtimes from the standpoint of whats in the fridge that needs to be used, rather than sourcing specific ingredients for a recipe they perhaps saw online. Home cooking is becoming more valued and less competitive. People are sharing more meals at home, and even at work. My hope is that we pay more attention to the way we talk about food; dietary regimes have become a means of self-definition a set of rules to follow, a clan to be a part of, which creates the potential to become divisive.

Plan your weekend with our Good Taste newsletter, offering wine advice and reviews, recipes, restaurant news and more. Sign up today.

Visit link:
How we'll eat in the decade ahead - The Globe and Mail

Posted in Genetic Engineering | Comments Off on How we’ll eat in the decade ahead – The Globe and Mail

Visually impaired Easton native finds a different path as an engineer – Enterprise News

Posted: January 5, 2020 at 4:10 am

Jack Duffy-Protentis said he has enjoyed working with his hands since childhood and looks forward to working in the automotive industry.

EASTON Jack Duffy-Protentis is less than a year away from graduating and starting a career as an engineer, a field that he enjoys because it allows him to work with his hands.

In addition to being a college student and learning concepts from chemistry and physics he has applied to his work, the Easton native has faced another challenge: being visually impaired.

"I do the same thing as everyone else, but I just have to find a different path," said Duffy-Protentis, who attends Worcester Polytechnic Institute and studies mechanical engineering.

Being visually impaired is challenging, the 22-year-old said. It adds more steps and time to do things, but that isn't a barrier.

"It's not stopped me from doing anything other than driving," Duffy-Protentis said.

His family realized that he had difficulty seeing in kindergarten when he struggled to read and write.

In the third grade, Duffy-Protentis was diagnosed with Stargardt's disease, a rare degenerative genetic disease that affects the retinas.

Duffy-Protentis recalled feeling relieved that he wasn't stupid. For his parents, the diagnosis was more difficult and they wanted to find a way to help him, whether it was through treatment or support.

"Part of Jack's success now and in life is that he doesn't have an attitude that is defeated," said his father Paul. "He's optimistic. He doesn't look at obstacles as obstacles. There are just challenges to overcome."

Today, Duffy-Protentis has about 20 percent of his vision left. His peripheral vision is good, but his central vision, where most details come from, has decreased.

He can make out shapes. When Duffy-Protentis looks at people, he looks at the tops of their heads and can understand where their features are, but can't see their facial expressions.

He has been interested in tinkering with things and later found that engineering would be a good fit for him. Duffy-Protentis wanted to find a school with a hands-on approach to learning like WPI.

After graduation in December, he wants to go into automotive engineering and work abroad with hypercar companies like Lamborghini, Ferrari or Sweden-based manufacturer Koenigsegg.

"Everything is mechanical and working in sync and relating to another system," Duffy-Protentis said about his interest in cars. "It all sort of comes together."

Before college, he restored a 1964 Mustang. Despite his diminishing vision, Duffy-Protentis has continued to work on it by using his sense of touch.

There were also other signs that he was mechanically inclined. Duffy-Protentis liked building toys, like Legos, and was a co-captain of the Oliver Ames High School robotics team.

He is also the only science person among his three siblings and cousins.

WPI is academically challenged and fast-paced, he said. For his senior project , Duffy-Protentis is working with a team of students to convert a gasoline jet ski into a solar energy and electric one. The goal is to build a prototype.

In class, he sits at the front of the room and takes pictures of notes on the board. He meets daily with a tutor to make sure he understood material from lectures.

To navigate, he has a guide dog named Adonis. Duffy-Protentis and the 2-year-old yellow Labrador retriever have been together since May after they graduated from a training school called Guiding Eyes for the Blind.

Duffy-Protentis said he is the first guide dog user at his university.

When he's not on the job, Adonis is a regular dog who likes to play and receive. Once the harness is on, he's focused.

Having Adonis has helped Duffy-Protentis feel more approachable, he said. When using a cane, people didn't really know how to act around him, but with a dog, he said people are more likely to interact with him or ask questions.

Adonis, the guide dog, has kept him company, but Duffy-Protentis has also made an effort to combat the social isolation of blindness.

His solution has been to become more of an extrovert and to introduce himself to people around campus.

His other interests include outdoor activities, like hiking, and board sports, like skiing and surfing. Being visually impaired helps him balance better, he said.

Duffy-Protentis is a member of the Society of Automotive Engineers and the Phi Sigma Kappa fraternity.

He knew that his fraternity was a good match for him when his brothers made an effort to include him in one of its traditions.

After members are accepted into the fraternity, they play a game of football. Duffy-Protentis planned to sit the game out because he can't see the ball when it's in the air.

Fraternity members asked if he could play soccer, which Duffy-Protentis can because he can see it better. The fraternity altered the tradition so that he could participate.

Beyond school, Duffy-Protentis has interned at a manufacturing center in Easton called Case Assembly Solutions that makes circuit boards.

He has volunteered a science, technology, engineering and math camp for children through the National Federation for the Blind and likes that he can be an example of a visually impaired engineer.

"There aren't many visually impaired engineers out there," Duffy-Protentis said.

Staff writer Mina Corpuz can be reached at mcorpuz@enterprisenews.com. Follow her on Twitter @mlcorpuz.

Here is the original post:
Visually impaired Easton native finds a different path as an engineer - Enterprise News

Posted in Genetic Engineering | Comments Off on Visually impaired Easton native finds a different path as an engineer – Enterprise News

Doctor Creates All-Natural Patch to CURB the Appetite and Maintain Weight Loss – GlobeNewswire

Posted: January 5, 2020 at 4:07 am

ST. LOUIS, MO, Dec. 30, 2019 (GLOBE NEWSWIRE) -- ST. LOUIS, MO (December 30, 2019) While losing weight can be difficult, most people will tell you that they are able to shed a few pounds (or more) by reducing calories, increasing exercise or doing a combination of both. Thats the good news. The bad news, however, is that according to some studies, 80%, and as many as 95% of people who lose weight will regain it within a few months to a year. Not a very optimistic statistic. Why does this happen?

"The answer is not so simple, said Dr. Zach LaBoube, founder of InsideOut Wellness and Weight Loss, and author of HCG 2.0 Dont Starve, Eat Smart and Lose: A Modern Adaptation of the Traditional HCG Diet. People gain their weight back for a variety of reasons, he added. For some, they simply fall back into old habits, eat out of boredom, or slack off on their exercise routine. For others, they could be fighting a very real physiological response of their body wanting to replenish fat reserves after weight loss, and theyre genuinely hungry! Whatever the reasons, I wanted to help.

LaBoube, who is currently practicing in Singapore, has seen chiropractic and acupuncture patients all over the world, from Peru to Indonesia. He believes that he learns as much about holistic wellness from his patients as they do from him. I'm currently working on a Master of Science in Nutrition & Human Performance from Logan University, but a lot of what I incorporate into my supplement line comes from indigenous herbs and remedies that I hear about from my patients, he added.

It was during his time in Southeast Asia, followed by Peru, that he began formulating what would ultimately become CURB, a trans-dermal patch designed to curb the appetite while increasing energy and focus.

CURB has been in the making for two years, said LaBoube. Its all natural. Nothing artificial. It has zero synthetic stimulants and no caffeine. All of the 29 ingredients were carefully selected to work synergistically with one another, he continued. To name a few, Wild African Mango helps lower cholesterol, suppresses the appetite, provides natural mood enhancement and absolutely blows up your metabolism. Green Tea Extract is a powerful antioxidant.Moringa Plant is a super food that feeds and supports soft tissue and is great for your skin. And, of course, I had to include Peruvian Maca. You can Google that one on your own!

All of his exotic ingredients, when accompanied by simple C and B Vitamins to facilitate absorption, each play a vital role in CURBs overall effectiveness. Other CURB ingredients include Cayenne Pepper (which boosts metabolism and helps burn fat), Chromium Polynicotinate (which helps block sugar cravings), Turmeric (a powerful anti-inflammatory and antioxidant), Rhodia (which increases resistance to physical and mental stress), Astragalus (which stimulates the immune system) and Beta-Alanine (which increases endurance and energy).

Since first introducing CURB a few months ago, LaBoube has received nothing but positive feedback from his patients, as well as those who are part of his private Facebook group, which has more than 19,000 members and continues to grow each day. Im very pleased to see that CURB is working and giving people the confidence they need to maintain their weight loss, he said. But I want to emphasize that CURB, alone, is not the cure all, he added. Yes, the ingredients have been found to suppress the appetite while providing energy and focus, and yes, those who use CURB have the peace of mind in knowing that theyre getting some extra help to keep their weight off. But, ultimately, they need to continue making smart choices about the foods they choose to eat to stay on track and avoid a set-back, he added. Maintaining your weight loss is as much about giving your body the proper nutrition it needs as it is about removing the garbage it doesn't.

CURB will help, but you have to do your part as well. CURB is available on the InsideOut Wellness website (www.InsideOutWellness.net). Twelve patches (a 36-day supply) are $55. For a limited time, use code SNOW2019 to receive 20% OFF.

Media Contact: Marcy ManningMarcy724@comcast.net847-712-0212

Via:https://story.kisspr.com/

More here:
Doctor Creates All-Natural Patch to CURB the Appetite and Maintain Weight Loss - GlobeNewswire

Posted in HCG Diet | Comments Off on Doctor Creates All-Natural Patch to CURB the Appetite and Maintain Weight Loss – GlobeNewswire

We reveal the New Years resolutions of every SEC football coach, what is on Coach Kiffins mind for 2020? – Red Cup Rebellion

Posted: January 5, 2020 at 4:06 am

The time has come for the annual rite of passage of improving oneself, setting goals, and ultimately forgetting all about the resolutions within like a couple weeks.

Cmon, you are definitely going to use that Peloton to stack clothes on instead of getting in shape, just be honest with yourself.

But if you are thinking of a New Years resolution, what better place to find inspiration than the hyper-competitive world of SEC coaching? I mean, these men are the 100-hour work week, seven or eight figure making, kings of this part of the country.

What could they possibly be thinking as the clock strikes midnight and we roll into 2020?

The reason why I have a process is so I can keep doing the process until the process is so simple I can process every minute of every day, so quit asking me about my resolution alright?!?! I mean, yeah, ok, Ive got plenty of time right now to think since were not in the playoff, but its all fine, ITS FINE, because theres a process. Im not going anywhere, right?!

[finally opens the Coke on his podium and chugs it all]

Ditto to whatever Coach Saban does, but Im definitely my own man for sure.

Grow out his big toes or shrink a couple toes to not have yeti feet, and if theres time, take up boxing .

[tweets picture of his boat with Ole Miss flag]

Winky emoji, gif of dolphin jumping through a fiery hoop fans debate the meaning of this resolution for the next three months.

(record retracted due to private schools being private and stuff) Lets just assume its wearing vests everywhere at all times forever.

Eat less red meat...doctors orders! BUT pork is a white meat so YESSSSIRRRRRRRRRRRRRRRRRRRRRRRRRRR!!!!!!!!

Quit smoking (does he smoke? you ask, I say its doesnt matter)

Buy a new pair of glasses for the first time since 2009 .

Totally not going to bring up my accomplishments at family gatherings any more, I dont need to do it, honestly, really its really fine that Bob is retired and did so well, and everyone says Im doing a great job. Im good enough! AND BY GOD PEOPLE LIKE ME!

Try to look like a head football coach instead of like a Mizzou fan who won a head coach for the day contest.

Get a Twittbook or Myface account, whatever these millennials are doing nowadays, continue being a dumb neanderthal.

Buy some oversized belt buckles, bolo ties, and chew hay more often.

Start every day with a shot of tabasco and douse skin liberally with Tony Chacheres (this has been his same resolution 20 years running); also cut down on sodium (also same resolution annually).

Gotta be #PoweredbytheT so Im getting testosterone shots every day until the National Championship 2021! Not that I need them, I DEFINITELY DONT NEED THEM BALD MEN ARE USUALLY WAY MORE VIRILE.

What are your Ole Miss resolutions for this next year? Will you stay for the second half of every football game? Comment or tweet @redcuprebellion with your 2020 plans.

Read the original post:
We reveal the New Years resolutions of every SEC football coach, what is on Coach Kiffins mind for 2020? - Red Cup Rebellion

Posted in Testosterone Shots | Comments Off on We reveal the New Years resolutions of every SEC football coach, what is on Coach Kiffins mind for 2020? – Red Cup Rebellion

Halting ALS with a gene therapy approach – FierceBiotech

Posted: January 5, 2020 at 4:05 am

An abnormality in the SOD1 gene is linked to some inherited cases of amyotrophic lateral sclerosis (ALS). So could turning off the mutated gene halt the disease? An international research team led by the University of California San Diego School of Medicine showed the potential of that strategy in mice by using a gene therapy approach.

A one-time injection of a gene-silencing RNA delivered by an adeno-associated virus (AAV) vector into the spinal cord prevented the onset of ALS in presymptomatic mice, and it blocked disease progression in rodents that had already developed symptoms. The team reported the findings in the journal Nature Medicine.

The SOD1 gene codes for an enzyme called superoxide dismutase. Normally, the enzyme breaks down superoxide radicals that are produced during cell metabolism. But in ALS, SOD1 mutations can create misfolded SOD1 protein, as toxic oxygen molecules persist, leading to the death of motor neurons.

How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC

CROs are often at the forefront of adopting new technologies to make clinical trials more efficient. Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.

The UC San Diego-led team postulated that a short hairpin RNA (shRNA)an artificial RNA molecule that can silence gene expressioncould be utilized to block the dysfunctional SOD1 gene.

Other researchers had tried delivering shRNA-bearing vectors into the blood via intravenous injection. In mouse models of ALS, disease progression was indeed slowed, but the approach only extended survival by about three months. In a more recent study, scientists used intrathecal injection into the cerebrospinal fluid, but the animals lived only two months longer despite being treated immediately after birth.

For the current study, the UCSD researchers injected the shRNA-containing AAV therapy into the spinal subpial space at cervical and lumbar spine levels.

The team observed impressive results. Remarkably, SOD1-mutated mice treated before disease onset never developed disabilities related to motor neuron functions when followed to an average age of 462 days. That means they didn't lose functions like grip strength ororientation reflexes. The control animals, by contrast,started showing symptomsat about 306 days and reached the end-stage of ALS about three months later.

Further analysis showed that the therapy suppressed the accumulation of misfolded SOD1 protein and almost completely preserved motor neuron cells.

In mice that had already entered the symptomatic stage, the injection also blocked disease progression and further motor neuron degeneration, the team reported.

At present, this therapeutic approach provides the most potent therapy ever demonstrated in mouse models of mutatedSOD1gene-linked ALS, the studys senior author, Martin Marsala of UCSD, said in a statement.

RELATED:Biogen's antisense ALS drug shows promise in early clinical trial

Several other strategies have been developed aimed at decreasing the production of mutated SOD1 protein. Swiss biotech Neurimmune has a recombinant antibody called -miSOD1, which the company developed based on memory B cells that are found in healthy elderly people and that protect against misfolded SOD1. In mouse models of ALS, the drug extended the animals lives by up to two months.

Antisense oligonucleotide therapy isanother potential modality for fighting neurodegenerative disease. Biogen recently showed its antisense drug tofersen (BIIB067) was well tolerated in ALS patients in a small phase 1 study. At its highest dose, the drug cutSOD1 protein levels in spinal fluid and the patients performed well on certain clinical function tests.

Marsala and colleagues now plan to run additional studies of their spinal subpial shRNA approach in a large animal model to determine the optimal, safe dosage of the treatment.

In addition, effective spinal cord delivery of AAV9 vector in adult animals suggests that the use of this new delivery method will likely be effective in treatment of other hereditary forms of ALS or other spinal neurodegenerative disorders that require spinal parenchymal delivery of therapeutic gene(s) or mutated-gene silencing machinery, such as in C9orf72 gene mutation-linked ALS or in some forms of lysosomal storage disease, Marsala said in the statement.

Read this article:
Halting ALS with a gene therapy approach - FierceBiotech

Posted in Gene therapy | Comments Off on Halting ALS with a gene therapy approach – FierceBiotech

Research Roundup: Controlling Gene Therapy and More – BioSpace

Posted: January 5, 2020 at 4:05 am

Every week there are numerous scientific studies published. Heres a look at some of the more interesting ones.

Controlling the Doses of Gene Therapy

Gene therapy is relatively new, with only a few approved therapies. The techniques typically involve taking a normal gene, inserting it into a hollowed-out virus, and injecting it into the patient, where the gene produces normal proteins that are otherwise abnormal. Researchers at The Scripps Research Institute developed a molecular switch that could potentially be embedded into gene therapies that would control dosing. They published their research in the journal Nature Biotechnology.

I think that our approach offers the only practical way at present to regulate the dose of a gene therapy in an animal or a human, said Michael Farzan, principal investigator of the research.

The researchers demonstrated the work by incorporating the switch into a gene therapy for anemia that produces the hormone erythropoietin. The switch suppressed expression of the gene to very low levels but could then increase the genes expression using injected control molecules called morpholinos. Morpholinos are already approved by the FDA as safe for other applications.

Machine Learning to Interpret Gene Regulation

Although big data is helpful in biological systems, the data sets are so complicated that interpreting the data is still difficult and complex. Researchers at Cold Spring Harbor Laboratory designed advanced machine learning algorithms that cut through the complexity, making the data from gene regulation more easy to understand for biologists. The algorithms are a form of artificial neural network (ANN) that appears to bridge the gap between computational tools and how biologists think.

Deep Learning Predicts Disease-Associated Mutations

Researchers at the University of Hong Kong developed a deep learning method to predict disease-associated mutations of the metal-binding sites in a protein. It is the first time a deep learning approach has been used to predict disease-associated metal-relevant site mutations of metalloproteins. Metal ions play important roles structurally or functionally in the pathophysiology of many human biological systems, such as zinc, iron and copper. Deficiencies in these can cause severe diseases. They utilized omics data to develop a training dataset, finding that a mutation in zinc-binding sites played a major role in breast, liver, kidney, immune system and prostate diseases, while calcium- and magnesium-binding sites are linked to muscular and immune system diseases, respectively. Iron-binding site mutations are associated with metabolic diseases.

The Science Behind Intermittent Fasting

There are, generally speaking, two types of intermittent fasting. One is daily time-restricted feeding, narrowing eating times to 6-8 hours per day, and 5:2 intermittent fasting, where individuals limit themselves to one moderate-sized meal two days a week. Research suggests that the reason this works is that they trigger metabolic switching, an evolutionary adaptation to periods of food scarcity. When people eat three meals a day plus snacks, the switching does not occur. The research study also found that intermittent fasting decreased blood pressure, blood lipid levels and resting heart rates. Additional studies also suggest it can improve brain health, such as learning and memory.

Many Younger Patients with Stomach Cancer Appear to Have Distinct Disease

Mayo Clinic researchers found that many people who developed stomach cancer under the age of 60 had genetically and clinically distinct disease from stomach cancer patients who were older. The new, early onset type of stomach cancer appears to grow and metastasize more quickly and has a worse prognosis. It is also more resistant to traditional chemotherapy. The investigators evaluated more than 75,225 cases from several databases to review stomach cancer statistics from 1973 to 2015. The average age of stomach cancer diagnosis is 68, but there appears to be growing occurrence in individuals in their 30s, 40s and 50s.

Dementia Vaccine Successful in Animal Trials

Investigators successfully tested an experimental vaccine to remove brain plaque and tau protein aggregates linked to Alzheimers disease in laboratory mice. The researchers from the Institute for Molecular Medicine and University of California, Irvine and Flinders University in South Australia, believe it supports clinical trials in humans, potentially in the next two years. The vaccine was a combination of two MultiTEP epitope vaccines, AV-1959R and AV-1980R, that target amyloid-beta and tau, respectively. It is formulated in AdvaxCpG, a polysaccharide adjuvant.

RNA-Targeting Approach Successfully Blocks Driver of Parkinsons Disease

Researchers at Scripps Research in Florida developed a compound that prevents production of an underlying cause of Parkinsons disease, an abnormal protein called alpha-synuclein. Dubbed Synucleozid, the protein halts the ribosome from detecting the messenger RNA (mRNA) template, preventing the translation of the disordered alpha-synuclein protein. This proof-of-concept study hints that the compound could become a potential Parkinsons drug candidate.

Read more here:
Research Roundup: Controlling Gene Therapy and More - BioSpace

Posted in Gene therapy | Comments Off on Research Roundup: Controlling Gene Therapy and More – BioSpace

Novel discovery in gene therapy to treat kidney diseases – Gulf News

Posted: January 5, 2020 at 4:05 am

Image Credit: Pixabay

New York: A team of researchers report a novel approach in which three different gene delivery vectors were injected intravenously and directly into the kidneys of mice, rekindling hope to treat kidney diseases with gene therapy.

Before gene therapy can be used to treat renal diseases, delivery of therapeutic genes to the kidney must become much more efficient.

Jeffrey Rubin, Tien Nguyen, Kari Allen, Katayoun Ayasoufi, and Michael Barry from the Mayo Clinic co-authored an article published in the journal Human Gene Therapy.

As the kidney filters out large compounds from the bloodstream, the researchers chose to study the ability to deliver three different sized vectors via an intravenous route: small adeno-associated virus (AAV) vectors (25 nm), larger adenovirus vectors (100 nm) and lentiviral vectors (120 nm).

To bypass this filtering mechanism, they also tested two different direct injection routes into the kidney and found these to be superior to intravenous injections.

However, some of the vectors were able to leak out of the kidney, creating the possibility for off-target tissue effects.

The potential for direct injections opens new possibilities for treating kidney diseases with gene therapy, but additional improvements are needed, the authors wrote.

"The Mayo Clinic team has performed an important head-to-head comparison of currently available gene therapy technology, to identify which may best be used to address this important group of diseases," said Terence R. Flotte, Dean, Provost and Executive Deputy Chancellor, University of Massachusetts Medical School.

Here is the original post:
Novel discovery in gene therapy to treat kidney diseases - Gulf News

Posted in Gene therapy | Comments Off on Novel discovery in gene therapy to treat kidney diseases – Gulf News

Page 1,214«..1020..1,2131,2141,2151,216..1,2201,230..»